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AbstrAct
Objectives To investigate factors associated with the 
return of home sampling kits for sexually transmitted 
infections (STIs).
setting Online STI testing service offered to the residents 
of Birmingham and Solihull.
Participants All patients requesting STI home sampling 
kits via the Umbrella sexual health service website 
between 15 July 2016 and 14 December 2016.
Interventions Associations between data collected at 
online registration and the rate of return of STI home 
sampling kits within 30 days of request was assessed.
results A total of 5310 kits were requested, of which 
3099 (58.4%) were returned to the medical microbiology 
laboratory. On multivariable analysis, women and men 
who have sex with men were similarly likely to return 
their sampling kits (adjusted OR (OR
adj) 1.06, 95% CI 0.86 
to 1.30), while heterosexual men were significantly less 
likely to return their sampling kits (ORadj 0.63, 95% CI 0.55 
to 0.72, p<0.001 vs women). Patients reporting symptoms 
were also less likely to return kits (ORadj 0.77, 95% CI 0.67 
to 0.89, p=0.001 vs asymptomatic patients). Kits that were 
delivered to the patient’s home, rather than to a clinic 
or pharmacy (p<0.001), and those requested from less 
economically deprived neighbourhoods (p=0.029) were 
significantly more likely to be returned.
conclusion STI self-sampling testing kits delivered 
to patients’ homes are most likely to be returned. 
Heterosexual men and those from more economically 
deprived areas are the less likely groups to return the 
kits. Further research on the barriers to return self-
sampling STI testing kits of these subgroups of patients is 
warranted.
trial registration number Registered with R&D 
department at University Hospitals Birmingham; 
CARMS-13551.
IntrOductIOn
The advent of new technologies has provided 
opportunities for expansion of screening for 
sexually transmitted infections (STIs) and 
HIV in general population. Home sampling 
kits for STI testing take advantage of the 
features of nucleic acid amplification tests 
(NAATs) for the detection of chlamydia and 
gonorrhea. The high sensitivity and speci-
ficity of the tests allows for testing of anogen-
ital specimens obtained by self-collecting 
procedures. New laboratory-based HIV assays 
can operate on small volume blood samples 
that can be obtained through a finger prick, 
and collected in a small blood tube that fits 
inside a small box or envelope. Specimens 
for NAAT can be stored at room temperature 
while being transported to the laboratory.
Home sampling STI and HIV testing 
provides optimal privacy, and the choice 
of being tested on any occasion. Because 
of savings on the cost of clinical overheads, 
home sampling STI testing services may be 
more cost-effective compared with tradi-
tional services. However, the service is also 
perceived to have a number of limitations, 
such as not being able to talk to a doctor 
about test results.1 Over the past two decades, 
several studies have reported on acceptability 
of home sampling for chlamydia and gonor-
rhea testing.2–6 Studies have also investigated 
the success of internet-based home sampling 
services for chlamydia testing.7 8 In England, 
76 842 individuals aged between 15 and 24 
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Research
strengths and limitations of this study
 ► The study showed large numbers of different sex 
groups tested for chlamydia, gonorrhea, HIV and 
syphilis by self-sampling kits delivered to their 
address of choice.
 ► Kits delivered to heterosexual men, those 
with symptoms, neighbourhoods with more 
socioeconomic deprivation and locations other than 
the patient’s home are the least likely to be returned.
 ► The study’s observational design made it difficult to 
investigate reason(s) for failure to return sampling 
kits.
 ► The findings of the study may help to improve the 
usage of similar services rolled out by other sexual 
health departments in the UK.
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Table 1 Contents of the four types of sampling kit
Female-
design A
Female-
design B Male MSM
Pictorial information and 
guidance leaflet
✓ ✓ ✓ ✓
Preaddressed return 
envelope
✓ ✓ ✓ ✓
Sterile disposable lancet 
and tiny blood bottle
✓ ✓ ✓ ✓
Urine sample bottle ✓ ✓
Vulvovaginal swab ✓ ✓
Anorectal swab ✓ ✓
Throat swab ✓
MSM, men who have sex with men.
years were tested for chlamydia using internet services in 
2015.9
Following the tendering process of sexual health 
services in England, many services are now expected to 
offer home sampling kits for STI screening. Improving 
return rates of home sampling kits would improve the 
cost-effectiveness of these services, while potentially 
enhancing the success of the services in reducing the inci-
dence of STI.
Studies reporting on the return rates of internet-regis-
tered home sampling kits have focused on the use of kits 
for chlamydia and gonorrhea testing or on HIV screening, 
and only on specific sex groups: men who have sex with 
men (MSM) or women.7 8 10 11 Limited data currently exist 
on the return rates of internet-registered home sampling 
kits for STI and HIV screening in general population.
The aim of this study was to investigate the rate of return 
of home sampling kits after registration with an online 
health website in the cities of Birmingham and Solihull, 
UK. To the best of our knowledge, this is the first report 
on return rate of home sampling kits offering combined 
chlamydia, gonorrhea, HIV and syphilis screening to all 
patients.
MethOds
Following the tender of the services by Birmingham 
and Solihull local governments, the new sexual health 
service (Umbrella Health) was formed in August 
2015. This offers an online service for requesting home 
sampling kits for STI and HIV, which can be used by any 
adult residents of Birmingham and Solihull and without 
the need for direct referral from their general practi-
tioners. The service is promoted online and through a 
number of local media outlets and venues, including 
community partnerships and primary care centres. Indi-
viduals are encouraged to visit the service’s website and 
request a sampling kit at the time of their convenience.
requesting sampling kits
The service allows for individuals’ self-registration on 
Umbrella Health website (https:// umbrellahealth. co. 
uk/ our- services/ self- sampling- kits). When applying for 
kits, individuals are asked a range for questions relating 
to sexual orientation, anogenital symptoms and sexual 
behaviours, in order to identify the appropriate type of 
sampling kit they should receive. All questions must be 
answered to complete the application process. Because 
of the risk of having an STI, individuals who report 
anogenital symptoms are advised to attend one of several 
community umbrella health clinics across Birmingham 
and Solihull. They are still able to request home sampling 
kits for STI screening.
After registration with the service, the individual can 
choose to receive their home sampling kits at their 
address of choice or to collect it from 1 of 66 locations 
in partnership with Umbrella Health, including 24 local 
pharmacies and 24 community sexual health clinics 
across Birmingham and Solihull.
contents of sampling kits
Depending on the responses given to questions when 
requesting, there are four different types of sampling 
kit that can be ordered, which are tailored to the risk 
profile of the patient. For women, there are two types of 
kit: ‘Design A’ is for patients who do not report having 
engaged in anal sex within the previous 6 months, and 
‘Design B’ is for those who answered yes to this question. 
Similarly, for men, the standard male kit is dispatched 
to those who do not report having sex with men within 
the previous 6 months, with an MSM kit being dispatched 
otherwise. The contents of the various sampling kits are 
summarised below and in table 1.
All four of the home sampling kits contain sterile dispos-
able lancets, to obtain finger prick blood samples, which 
are collected in the included tiny blood bottles. The aim 
is to collect a minimum of 400 µmL, so that samples can 
be used for HIV and syphilis serology testing. The female 
kits also include the swabs and manufacturer’s transport 
media for chlamydia and gonorrhea testing on an Aptima 
Combo assay. Both of the female kits include a vulvovag-
inal swab, with the design B kit additionally including 
an anorectal swab. The two male kits also include urine 
sample bottles for urethral testing, while the MSM kit 
additionally includes anorectal and throat swabs.
All kits contain pictorial information and guidance 
on how to obtain the appropriate sample for each test. 
They also hold an envelope preaddressed to the medical 
microbiology laboratory at Queen Elizabeth Hospital 
Birmingham. The packaging of the kits complies with 
Royal Mail standards requiring three layers of pack-
aging. This includes a watertight leakproof container 
for the sample, packed with enough porous material to 
absorb all fluids in case of breakage, which is enclosed in 
a second watertight leakproof container. The two layers 
of packaging are then enclosed in a third outer package 
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to protect against external damage during the delivery of 
the specimens.
testing of samples
On receipt of specimens from the home sampling kits, 
their unique number is entered in the medical microbi-
ology laboratory registry system. Individuals’ details are 
then automatically retrieved from the web-booking data-
base. The specimens are simultaneously registered in the 
sexual health service’s electronic patients’ system. The 
specimens are then processed according to UK medical 
laboratory standards. Chlamydia and gonorrhea tests are 
carried out on an Aptima Combo assay and platform. 
HIV serology is carried out on Abbott’s fourth-generation 
ELISA HIV assay, and the enzyme-linked ummunosor-
bent assay for IgG against treponemal antibodies assay is 
used for syphilis screening.
Patients were informed of their test results by a text 
message to their mobile phones within 1 hour of their 
authorisation by the laboratory.
study design
This was service evaluation study of factors associated 
with return of STI sampling kits within 30 days of their 
online request through the Umbrella Health website. 
The analysis was based on anonymised retrospective 
data and, as such, we did not seek ethics committee 
approval.
data collection
Data were collected on patients requesting STI and HIV 
sampling kits from Umbrella Health website between 15 
July 2016 and 14 December 2016. Information on patients’ 
demography and responses to questions relating to drug 
usage, sexual history and symptoms were recorded. Since 
all of these questions needed to be completed in order to 
request a sampling kit, complete data were available for 
all of these factors.
The final question of the online registration was in two 
parts, first asking if the patient had a history of unpro-
tected sex with someone born or raised outside of a list 
of 16 countries. A negative response to this revealed the 
second part of the question, asking whether the patient 
was born or raised outside of the countries listed. The 
16 countries in the list were: Austria, Belgium, Czech 
Republic, Denmark, Faroe Islands, Finland, France, 
Germany, Iceland, Ireland, Luxembourg, The Nether-
lands, Norway, Sweden, Switzerland and the UK (which 
will be subsequently referred to the ‘Northern EU’ for 
brevity). We consider these 16 Northern European coun-
tries to have low overall prevalence of hepatitis B infec-
tion. Individuals that were born and raised, or have sex 
with partners from outside the Northern EU may be at 
increased risk of hepatitis B infection. Hence, in accor-
dance with National Institute for Health and Care Excel-
lence guidelines, the website advises those individuals 
to attend one of Umbrella Health clinics for hepatitis B 
screening and vaccination.12
Temporal factors relating to the day and time that the 
request for sampling kits was placed were also collected 
automatically by the website. All individuals were required 
to provide a postcode, which was converted to a 2015 
Index of Multiple Deprivation Score (IMD), based on the 
data from the Department for Communities and Local 
Government.13 For 39 cases, the given postcodes were 
not available in the IMD database, hence these cases were 
excluded from the analysis of IMD score.
The medical microbiology laboratory system was 
then interrogated to identify which of the individuals 
requesting sampling kits actually returned samples.
statistical analysis
Initially, the proportions of STI sampling kits where a 
sample was returned were compared across the factors 
using χ2 tests or Mann-Whitney tests, as appropriate. 
Continuous variables were expressed as medians and 
IQRs. For some of the questions in online registration, 
a different set of answers was displayed, depending on 
the gender of the respondent. In these cases, the analyses 
were performed separately for men and women, with the 
small number of transgender respondents excluded.
A multivariable binary logistic regression model was 
then produced, to identify significant independent 
predictors of the return of samples. The transgender 
respondents were also excluded from this analysis, due to 
the small number of cases, as were those cases where the 
IMD score was unavailable. A forwards stepwise approach 
was used to select factors for inclusion in the model.
All analyses were performed using IBM SPSS V.22 (IBM 
Corp), with p<0.05 deemed to be indicative of statistical 
significance throughout.
results
Between the 15 July 2016 and the 14 October 2016, a total 
of 5310 kits were requested, of which 3099 (58.4%) were 
returned to the medical microbiology laboratory. The age 
distributions were similar in the groups of patients who 
did and did not return sampling kits, with a median of 
24 years (IQR: 20–28) for both (p=0.100). Associations 
between other factors and the return rate of kits are 
reported in table 2a,b.
On univariable analysis, women were found to be 
significantly more likely than men to return sampling kits 
(61.2% vs 53.1%, p<0.001). There was also a small group 
of 10 transgender respondents, who were the least likely 
to return kits, with only 10% (n=1) doing so. Analysis 
of gender was then further broken down by the type of 
kit requested. Women were found to have similar rates 
of kit return, regardless of whether or not they reported 
having receptive anal sex (61.3% vs 59.6% for design A 
vs design B, p=0.572). Of the male respondents, those 
requesting an MSM kit had a similar rate of kit return to 
females, at 62.5% (p=0.416). However, heterosexual men 
were significantly less likely to return kits (p<0.001), with 
only 49.6% doing so.
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Table 2a Comparisons of the rates of samples received by 
temporal factors and survey responses
STI
kits
Samples
received p-Value
Day of request 0.059
  Monday 936 550 (58.8%)
  Tuesday 882 510 (57.8%)
  Wednesday 888 518 (58.3%)
  Thursday 814 454 (55.8%)
  Friday 738 435 (58.9%)
  Saturday 466 257 (55.2%)
  Sunday 586 375 (64.0%)
Time of day 0.665
  8:00–12:59 1437 858 (59.7%)
  13:00–17:59 1702 980 (57.6%)
  18:00–22:59 1407 818 (58.1%)
  23:00–7:59 764 443 (58.0%)
Gender <0.001*
  Female 3513 2149 (61.2%)
  Male 1787 949 (53.1%)
  Transgender (female to 
male)
3 0 (0.0%)
  Transgender (male to 
female)
7 1 (14.3%)
Place of kit collection/delivery <0.001
  Home 4115 2495 (60.6%)
  Clinic 633 357 (56.4%)
  Pharmacy 562 247 (44.0%)
History of sex with someone with infections in the 
last 6 months
0.085
  None of these 
infections
4747 2782 (58.6%)
  Chlamydia or NSU 469 267 (56.9%)
  Gonorrhea 52 35 (67.3%)
  Hepatitis B or C 12 4 (33.3%)
  HIV 11 5 (45.5%)
  Syphilis  8 2 (25.0%)
  Trichomoniasis 10 4 (40.0%)
Country of birth questions† 0.031
  Neither option 4407 2605 (59.1%)
  Unprotected sex with 
someone born outside 
Northern EU
715 398 (55.7%)
  Respondent born 
outside Northern EU
187 96 (51.3%)
2015 IMD rank‡ 0.007
  <5000 1855 1039 (56.0%)
  5000–14 999 2095 1239 (59.1%)
  15000+ 1321 798 (60.4%)
Continued
STI
kits
Samples
received p-Value
p Values are from χ2 tests, unless stated otherwise, and bolded 
p values are significant at p<0.05.
*A comparison of male versus female (excluding transgender) was 
also significant at p<0.001.
 †Combines the questions: ‘Do you have a history of unprotected 
sex with someone born or raised outside any of the countries 
listed?’ and ‘Were you born outside of the countries listed?’, as the 
latter is only asked if an answer of ‘No’ is given to the former.
‡Excludes the n=39 with for whom the IMD was not available, 
and p value is from a Mann-Whitney test, treating the IMD rank as 
continuous.
IMD, Index of Multiple Deprivation Score; STI, sexually transmitted 
infection.
Table 2a Continued 
Analysis of the deprivation score  IMD 2015 of the area 
from which the kits were requested found that those who 
returned kits gave postcodes which were in significantly 
less deprived areas, with a median IMD rank of 9444 (IQR: 
2907–15 387) compared with 8574 (IQR: 2546–14 338) 
for areas that did not return the kits (p=0.007). In addi-
tion, the place of delivery of the sampling kits was also 
significantly associated with their return (p<0.001), with 
the greatest rate of return observed in those kits deliv-
ered to the patient’s homes (60.6%) and the lowest rate 
in those delivered to pharmacies (44.0%). Neither the 
day of the week (p=0.059), nor the time of day (p=0.665) 
that the request was made were found to be significantly 
predictive of whether a kit would be returned.
A significant association with the questions about coun-
tries of birth of the patient and their sexual partners was 
detected (p=0.031), with patients born within and with 
partners within UK/Northern EU having the highest rate 
of return of the samples (59.1%) and those born outside 
the Northern EU having the lowest rate (51.3%). In addi-
tion, asymptomatic patients were found to be more likely 
to return their sampling kits compared with those with 
symptoms, regardless of gender (p=0.020 for women, 
p=0.010 for men). However, the rate of return of the 
samples did not differ significantly with the history of sex 
with someone with STI (p=0.085).
A multivariable analysis was then performed, to identify 
independent predictors of the return of samples, which 
returned results that were consistent with the univariable 
analysis (table 3). The type of kit requested was found 
to be significantly predictive of the return of samples 
(p<0.001). The rates of return were similar for women 
without or with history of anal sex (adjusted OR (ORadj) 
0.96, 95% CI 0.74 to 1.24, p=0.736) and the male MSM 
kit (ORadj 1.06, 95% CI 0.86 to 1.30, p=0.593). However, 
patients requesting the heterosexual male STI kit were 
significantly less likely to return samples than those 
requesting the other kit types (ORadj 0.63, 95% CI 0.55 to 
0.72, p<0.001 vs women without history of anal sex).
The place of delivery of the sampling kits was also 
a significant independent predictor of the return of 
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Table 2b Comparisons of the rates of samples received by gender-specific questions
Female Male
STI kits Sample received p Value STI kits Sample received p Value
Kit type* 0.572 <0.001
  Female-design A 3246 1990 (61.3%) † –
  Female-design B 267 159 (59.6%) † –
  Male STI † – 1325 657 (49.6%)
  MSM STI † – 462 292 (63.2%)
Symptoms 0.020 0.010
  I don’t have any of these symptoms 2769 1723 (62.2%) 1424 781 (54.8%)
  Deep pain during sex 151 83 (55.0%) † –
  Ongoing lower abdominal pain 215 132 (61.4%) † –
  Pain when you pass urine 299 174 (58.2%) 146 75 (51.4%)
  Sores, ulcers or cuts on your genitals or 
around your anus
79 37 (46.8%) 46 20 (43.5%)
  Pain in your testicles † – 73 36 (49.3%)
  Unusual discharge from penis or anus † – 98 37 (37.8%)
Sexual and drug taking behaviour (in the last 
6 months)
0.736 <0.001
  None of these statements apply to me 2961 1810 (61.1%) 1300 644 (49.5%)
  I’ve had anal sex with a man 213 126 (59.2%) † –
  I’ve had sex with six or more men 301 186 (61.8%) 12 5 (41.7%)
  I’ve used amyl nitrate (poppers) 11 8 (72.7%) 5 1 (20.0%)
  I’ve used methamphetamines 27 19 (70.4%) 23 13 (56.5%)
  I’ve had sex with other men † – 438 279 (63.7%)
  I’ve had receptive anal sex (I was the 
bottom) with a man
† – 9 7 (77.8%)
Excludes the transgender respondents (n=10). p-values are from χ2 tests, and bold p values are significant at p<0.05.
*Female-design B is for respondents reporting a history of receptive anal sex.
†Not applicable to the specified gender.
MSM, men who have sex with men; STI, sexually transmitted infection.
samples (p<0.001), with those delivered to the pharmacy 
the least likely to be returned (ORadj 0.53, 95% CI0.44 
to 0.63, p<0.001 vs home). Patients reporting symptoms 
were also less likely to return kits, (ORadj 0.77, 95% CI 0.67 
to 0.89, p=0.001 vs asymptomatic patients).
Decreasing deprivation was associated with an increased 
chance of the return of kits. For each increase of 10 000 
ranks in the IMD score (ie, becoming less deprived), the 
likelihood of kits being returned increased, with an ORadj 
of 1.08 (95% CI 1.01 to 1.15, p=0.029).
dIscussIOn
We identified a number of factors associated with return 
of STI and HIV sampling kits. Kits requested by hetero-
sexual men, those with genitourinary symptoms and kits 
delivered to neighbourhoods with higher socioeconomic 
deprivation and to locations other than the patient’s 
home were all found to have significantly lower rates of 
return.
Little comparable evidence for an online service for 
STI and HIV testing of all sex groups is currently avail-
able. Most studies report on home sampling services for 
HIV or chlamydia testing. In an earlier population study 
on uptake of postal screening for chlamydia, 25% (95% 
CI 21.7% to 28.6%) of 14 382 randomly selected men and 
women returned their sampling kits.14 An online HIV 
home sampling service for MSM reported 55% of 10 323 
men returned their sampling kits, a rate comparable with 
that for MSM in our study.10 In an earlier study on the 
uptake of home sampling of vaginal chlamydia testing, 
31% (350/1139) of the kits requested via email were 
returned.7 A study on home sampling kits for STI testing 
of 433 HIV negative MSM reported a return rate of 47%.11
Chlamydia trachomatisOnline surveys of target popula-
tions for home STI and HIV testing have identified some 
factors associated with the use of the service and return 
of the sampling kits. In a survey of 7938 MSM, those who 
identified themselves as gay or bisexual were more likely 
to use home sampling testing than men who identified 
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Table 3 Multivariable analysis of return of samples
ORadj (95% CI) p Value
Kit type* <0.001
  Female-design A – –
  Female-design B 0.96 (0.74 to 1.24) 0.736
  Male STI 0.63 (0.55 to 0.72) <0.001
  MSM STI 1.06 (0.86 to 1.30) 0.593
Place of delivery <0.001
  Home – –
  Clinic 0.84 (0.71 to 1.00) 0.048
  Pharmacy 0.53 (0.44 to 0.63) <0.001
Any symptoms reported 0.77 (0.67 to 0.89) <0.001
2015 IMD rank (x10 000)† 1.08 (1.01 to 1.15) 0.029
Results are from a multivariable binary logistic regression model, 
using a forwards stepwise approach. All factors in table 2a,b were 
considered for inclusion, as well as patient age. The questions 
regarding sexual infections, symptoms and statements about 
sexual and drug history were dichotomised into yes/no responses. 
The 10 transgender respondents and the 39 cases where the IMD 
was not available were excluded. Bold p values are significant at 
p<0.05.
*Female-design B is for respondents reporting a history of 
receptive anal sex.
†The OR represents the increase in the odds of sample return 
associated with an increase of 10 000 ranks of the IMD.
IMD, Index of Multiple Deprivation Score; MSM, men who have 
sex with men; ORadj, adjusted odds ratio; STI, sexually transmitted 
infection.
as straight/other men.1 Other surveys have identified 
level of education, level of income, ethnicity and age 
as predictor of return of the sampling kits.15–18 Some of 
these findings have not been supported by other surveys.1
In our study, sampling kits collected from pharmacies 
were less likely to be returned. This may be secondary to 
individuals’ difficulties with securing a venue where they 
can obtain their specimens in a confidential manner. 
Rates of return were also found to be lower in patients 
with genitourinary symptoms. We hypothesise that this 
may have been due to patients deciding to attend our 
sexual health clinics, rather than return their sampling 
kits, as this is the advice we offer to the patients on our 
website.
We found that heterosexual men and those from neigh-
bourhoods with higher socioeconomic deprivation were 
less likely to return their sampling kits. As these are popu-
lations at risk of STI and HIV,19 increasing the return rate 
of sampling kits from these populations is a priority for 
our service. However, based on the data available from 
the surveys, we were not able to hypothesise as to why 
these groups were less likely to return their samples and, 
as such, are not able to propose changes to the service to 
improve sample return.
We suspect improving the process of obtaining speci-
mens would improve the return of the testing kits. We aim 
to survey patients who do not return their STI sampling 
kits to understand their reasons for non-return of the 
testing kits better.
Our study suffered from a number of limitations, the 
main one being that, in patients who did not return their 
sampling kits, the rationale behind this decision was not 
known. This additional information may have been highly 
valuable in explaining the observed differences between 
subgroups (eg, heterosexual men vs MSM) and identi-
fying areas in which the service and, hence, the return 
rate of kits could be improved. As a result, a question-
naire targeted at those patients who did not return their 
kits would make for interesting further work in this area. 
However, the response rates to such questionnaires is 
likely to be poor, especially since the majority of patients 
of interest are likely to be non-responders, on account 
of the fact that they did not return their sampling kits. 
Consequently, such a study may be hampered by selection 
bias and a small sample size.
In this study, we assumed all requested kits were deliv-
ered to the patients but, since proof of delivery was not 
recorded, we do not know how many of the sampling 
kits were actually received. The number of kits lost in 
transit would be expected to be minimal. However, since 
the service was free, a number of online requests for the 
sampling kits may have not been genuine and may have 
used false delivery addresses, which would likely have 
resulted in the unwitting recipient disposing of the kit.
The study also only focused on whether or not the kits 
were returned, and did not consider the quality or quan-
tity of the samples themselves. As such, it is likely that a 
proportion of those kits returned contained incomplete 
or inadequate specimens on which the full range of STI 
and HIV sampling could not be performed. Further 
assessment of the factors associated with the return of 
incomplete samples may have yielded useful results. 
However, anonymised data relating to the samples were 
not available, hence this was outside the scope of this 
service evaluation.
Home sampling for STI and HIV testing is rapidly 
becoming a standard of care. Return of samples for testing 
is crucial for the success of the service. We identified a 
number of factors that were associated with non-return 
of the sampling kits. Further research into the subgroups 
of patients with the lowest return rates may identify the 
reasons behind this and changes to the service that could 
improve the rate of return and, hence, the effectiveness 
of the programme.
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